Tatiana K. Galperine

Lausanne, VD, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications

Fecal microbiota transplantation versus vancomycin or fidaxomicin in Clostridioides difficile infection first episode and first recurrence: a study protocol for a randomised, controlled, open-label, multicentre phase III clinical trial.

Fecal microbiota transplantation versus vancomycin or fidaxomicin in Clostridioides difficile infection first episode and first recurrence: a study protocol for a randomised, controlled, open-label, multicentre phase III clinical trial.

Journal: BMJ open
Published: August 28, 2026

Resolution of long-term severe irritable bowel syndrome following fecal microbiota transplantation: A case report and microbiota analysis.

Resolution of long-term severe irritable bowel syndrome following fecal microbiota transplantation: A case report and microbiota analysis.

Journal: Gut microbes reports
Published: March 30, 2026

Fecal Microbiota Transplantation Donor Screening: Is Dientamoeba fragilis a Valid Criterion for Donor Exclusion? A Longitudinal Study of a Swiss Cohort.

Fecal Microbiota Transplantation Donor Screening: Is Dientamoeba fragilis a Valid Criterion for Donor Exclusion? A Longitudinal Study of a Swiss Cohort.

Journal: Microorganisms
Published: October 30, 2025

Fecal microbiota transplantation in compassionate indications: French experience from 2019 to 2022.

Fecal microbiota transplantation in compassionate indications: French experience from 2019 to 2022.

Journal: Infectious diseases now
Published: May 22, 2025

A Randomized Controlled Trial of Efficacy and Safety of Fecal Microbiota Transplant for Preventing Recurrent Clostridioides difficile Infection: The Failure of a Procedure, not of a Therapy.

A Randomized Controlled Trial of Efficacy and Safety of Fecal Microbiota Transplant for Preventing Recurrent Clostridioides difficile Infection: The Failure of a Procedure, not of a Therapy.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 15, 2025

Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5-Year French National Survey.

Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5-Year French National Survey.

Journal: Alimentary pharmacology & therapeutics
Published: April 24, 2024

Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Can Be the Best Therapeutic Option in Severely Immunocompromised Patients Depending on a Case-by-Case Assessment of the Benefit-to-Risk Ratio.

Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Can Be the Best Therapeutic Option in Severely Immunocompromised Patients Depending on a Case-by-Case Assessment of the Benefit-to-Risk Ratio.

Journal: Gastroenterology
Published: March 28, 2024

Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practice.

Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practice.

Journal: Swiss medical weekly
Published: September 28, 2023

Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort.

Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort.

Journal: BMC infectious diseases
Published: April 04, 2023

Dry alginate beads for fecal microbiota transplantation: From model strains to fecal samples.

Dry alginate beads for fecal microbiota transplantation: From model strains to fecal samples.

Journal: International journal of pharmaceutics
Published: March 07, 2023

Cytomegalovirus in donors for fecal microbiota transplantation, the phantom menace?

Cytomegalovirus in donors for fecal microbiota transplantation, the phantom menace?

Journal: PloS one
Published: January 23, 2023

Fecal microbiota transplantation: a review on current formulations in Clostridioides difficile infection and future outlooks.

Fecal microbiota transplantation: a review on current formulations in Clostridioides difficile infection and future outlooks.

Journal: Expert opinion on biological therapy
Published: June 28, 2022
Showing 1-12 of 38

Last Updated: 09/26/2026